Tsujimoto, Akiko
Sudo, Kentaro
Nakamura, Kazuyoshi
Kita, Emiri
Hara, Ryusuke
Takayama, Wataru
Ishii, Hiroshi
Yamaguchi, Taketo
Article History
Received: 14 March 2019
Accepted: 18 October 2019
First Online: 7 November 2019
Competing interests
: Hiroshi Ishii reports honoraria from Yakult Honsha, Taiho Pharmaceutical, Eisai, TOWA and Teijin Pharma, and a consulting role for Ono Pharmaceutical, outside the submitted work. Other authors declare no conflict of interest.